cas 59107-51-6|| where to buy 8-chloronaphthalen-1-amine

Produktname:8-chloronaphthalen-1-amine

IUPAC Name:8-chloronaphthalen-1-amine

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM141452-25g	in stock	ƚŌƚ
CM141452-100g	in stock	ŤŮŮ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 59107-51-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:59107-51-6; Molekulare Formel:C10H8ClN; Schmelzpunkt:-; SMILES-Code:ClC1=CC=CC2=CC=CC(N)=C12; Dichte:

: Katalognummer:CM141452; Molekulargewicht:177.63; Siedepunkt:; Mdl-Nr.:MFCD00465087; Lagerung:Keep in a tight container nitrogen protection，and store at ambient temperature，protect from light

: Naphthalenes; Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.